Up next

Autoplay

Mini-Lecture Series: Bictegravir-Tenofovir alafenamide-Emtricitabine

0 Views • 08/17/25
Share
Side Effects
Side Effects
Subscribers
0

Dr. Brian Wood reviews the combination antiretroviral medication bictegravir-tenofovir alafenamide-emtricitabine and highlights key clinical trial data, indications, potential side effects, and drug resistance. For more videos visit the National HIV Curriculum website: https://hiv.uw.edu/mini-lectures.

0:00 Intro
0:18 Bictegravir-Tenofovir alafenamide-Emtricitabine
0:39 INSTIs
1:27 NRTIs
1:54 Clinical Reminders
3:40 Inhibition of Tubular Secretion of Creatinine
4:27 Key Studies
4:46 GS-380-1489 Week 48 Results
6:48 GS-380-1490 Week 48 Results
8:29 GS-380-1878
9:38 GS-380-1878 Results
10:12 BRAAVE2020
11:01 BRAAVE2020 Results
11:51 Resistance
13:41 Weight Change
15:54 Summary

Show more
0 Comments sort Sort By

Up next

Autoplay